Commit To Purchase Viridian Therapeutics At $12.50, Earn 37% Annualized Using Options
March 15, 2024 at 11:51 AM EDT
Investors considering a purchase of Viridian Therapeutics Inc (VRDN) shares, but cautious about paying the going market price of $17.24/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $12.50 strike, which has a bid at the time of this writing of $2.75..